My rebuttal:
The government’s “new” plan they offer the use of Pfizer’s experimental antiviral drug, called Paxlovid, that was approved based on a single trial with questionable results. Moreover, this drug cannot be taken by anyone on an SSRI or cardiovascular medication. This exclusionary criterion encompasses a significant portion of…
The government’s “new” plan they offer the use of Pfizer’s experimental antiviral drug, called Paxlovid, that was approved based on a single trial with questionable results. Moreover, this drug cannot be taken by anyone on an SSRI or cardiovascular medication. This exclusionary criterion encompasses a significant portion of the overall population.
• The FDA and NIH are once again putting profits before public health. In mentioning the Pfizer drug by name in the State of the Union Address, the president is showing the clear bias the government has for expensive, high-profit drugs while ignoring lower-cost, readily and widely available treatments like, fluvoxamine, ivermectin, and hydroxychloroquine.
• What was left out of the president’s remarks about the Pfizer drug is that it is not widely available. Although the government has agreed to by 50,000 courses of Paxlovid at $535 each dose with a total cost of $720 million, the drug is only available in very limited quantities.
• So, knowing that a large portion of the population cannot take Paxlovid, and the drug is in limited supply, and has uncertain efficacy, how is including it the plan as an early treatment an effective way of managing the COVID-19 pandemic for all Americans?
• The plan continues to use vaccines as a first line of defense against COVID-19. This approach has been proven wrong time and time again, especially with the COVID variants. Some of the most vaccinated populations such as Israel, have the same or more COVID cases in those countries that have far lower vaccination rates.
• An effective plan for managing COVID-19 is needed. A plan that protects the doctor-patient relationship.
• We need a plan that allows doctors to practice medicine without fear using their expertise and knowledge of their patient rather than rely on what an anonymous bureaucrat far away believes in the best treatment.
• If the government was serious about early treatment, this plan would include the use of the wide variety of FDA approved medications that have been long proven to be effective in preventing and treating COVID-19 and have saved countless lives around the world.
My rebuttal:
The government’s “new” plan they offer the use of Pfizer’s experimental antiviral drug, called Paxlovid, that was approved based on a single trial with questionable results. Moreover, this drug cannot be taken by anyone on an SSRI or cardiovascular medication. This exclusionary criterion encompasses a significant portion of the overall population.
• The FDA and NIH are once again putting profits before public health. In mentioning the Pfizer drug by name in the State of the Union Address, the president is showing the clear bias the government has for expensive, high-profit drugs while ignoring lower-cost, readily and widely available treatments like, fluvoxamine, ivermectin, and hydroxychloroquine.
• What was left out of the president’s remarks about the Pfizer drug is that it is not widely available. Although the government has agreed to by 50,000 courses of Paxlovid at $535 each dose with a total cost of $720 million, the drug is only available in very limited quantities.
• So, knowing that a large portion of the population cannot take Paxlovid, and the drug is in limited supply, and has uncertain efficacy, how is including it the plan as an early treatment an effective way of managing the COVID-19 pandemic for all Americans?
• The plan continues to use vaccines as a first line of defense against COVID-19. This approach has been proven wrong time and time again, especially with the COVID variants. Some of the most vaccinated populations such as Israel, have the same or more COVID cases in those countries that have far lower vaccination rates.
• An effective plan for managing COVID-19 is needed. A plan that protects the doctor-patient relationship.
• We need a plan that allows doctors to practice medicine without fear using their expertise and knowledge of their patient rather than rely on what an anonymous bureaucrat far away believes in the best treatment.
• If the government was serious about early treatment, this plan would include the use of the wide variety of FDA approved medications that have been long proven to be effective in preventing and treating COVID-19 and have saved countless lives around the world.
ABSOLUTELY ON THE MONEY.